Metformin for aging and cancer prevention | Zendy

Vladimir N. Anisimov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Metformin for aging and cancer prevention

Author(s) -

Vladimir N. Anisimov

Publication year - 2010

Publication title -

aging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.473

H-Index - 90

ISSN - 1945-4589

DOI - 10.18632/aging.100230

Subject(s) - hyperinsulinemia , metformin , carcinogenesis , longevity , life span , cancer , endocrinology , klotho , medicine , insulin , calorie restriction , biology , diabetes mellitus , caloric theory , cancer research , pharmacology , insulin resistance , gerontology , kidney

Studies in mammals have led to the suggestion that hyperglycemia and hyperinsulinemia are important factors in aging. Insulin/insulin-like growth factor 1 (IGF-1) signaling molecules that have been linked to longevity include daf-2 and InR and their homologues in mammals, and inactivation of the corresponding genes increases life span in nematodes, fruit flies and mice. It is possible that the life-prolonging effect of caloric restriction is due to decreasing IGF-1 levels. Evidence has emerged that antidiabetic drugs are promising candidates for both life span extension and prevention of cancer. Thus, antidiabetic drugs postpone spontaneous carcinogenesis in mice and rats, as well as chemical and radiation carcinogenesis in mice, rats and hamsters. Furthermore metformin seems to decrease cancer risk in diabetic patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research